What's New
Front Page
The Lived Experience of FTD: Overeating and Other Temptations in FTD
By Anne Fargusson, RN, AFTD Persons with FTD Advisory Council Among the hallmark symptoms of FTD is…
Advancing Hope: AFTD Hosts 2025 Holloway Summit
Can the risk of developing FTD be changed by environmental exposures, lifestyle, diet, and other factors? Are…
Pair of Studies Make Significant Findings in Search for FTD Biomarkers
Two recent studies on proteins and FTD are helping to lay the foundation for the potential development…
Dear HelpLine: Looking for Support Options
Dear HelpLine, My brother was diagnosed with FTD. I see that AFTD offers support groups, but I’m…
Study Examines Nature of Criminal Risk Behaviors in Dementia
An Australian Study uses an experimental screening tool to examine the propensity and nature of criminal risk…
Statement from The Association for Frontotemporal Degeneration (AFTD) on Disruption of Scientific Research Funding and Activities
The Association for Frontotemporal Degeneration (AFTD) is deeply concerned about recent policy changes and layoffs at the…
Guest Feature: The Story Behind the Story – Our Journey Through FTD and Why I Wrote “Welcome to the Honey B & B”
Novelist Melody Carlson drew from her family’s FTD story to write her latest book, Welcome to the…
AFTD Webinar: At the Intersection of FTD and the Law
FTD can present with executive dysfunction, impulsivity, loss of empathy, apathy, and disinhibition. At times, these symptoms…
Passage Bio Announces Interim Data for UpliFT-D Trial for FTD-GRN
Biotechnology company Passage Bio released interim data for its upliFT-D clinical trial for its gene replacement therapy…
Advocacy Update: Protect FTD Research Today!
Calling all AFTD advocates – federal funding for FTD research is at risk, and we need your…
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)